Convergence Investment Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,385
Closed -$992K 190
2022
Q4
$992K Buy
32,385
+4,975
+18% +$149K 0.59% 61
2022
Q3
$676K Buy
27,410
+4,264
+18% +$141K 0.44% 77
2022
Q2
$741K Buy
23,146
+175
+0.8% +$6.44K 0.45% 82
2022
Q1
$723K Sell
22,971
-7,979
-26% -$250K 0.37% 85
2021
Q4
$1.04M Sell
30,950
-86
-0.3% -$2.68K 0.53% 75
2021
Q3
$902K Sell
31,036
-17,588
-36% -$569K 0.48% 78
2021
Q2
$1.69M Buy
+48,624
New +$1.61M 0.73% 52
2018
Q2
Sell
-637
Closed -$31K 410
2018
Q1
$31K Buy
+637
New +$31.8K ﹤0.01% 509
2017
Q4
Sell
-41,711
Closed -$2.11M 300
2017
Q3
$2.11M Buy
41,711
+285
+0.7% +$13.4K 0.3% 128
2017
Q2
$1.57M Sell
41,426
-10,829
-21% -$427K 0.23% 171
2017
Q1
$2.01M Sell
52,255
-112,705
-68% -$3.39M 0.28% 134
2016
Q4
$3.64M Sell
164,960
-48,270
-23% -$991K 0.5% 55
2016
Q3
$3.41M Buy
+213,230
New +$2.44M 0.5% 55
2015
Q4
Sell
-257,592
Closed -$1.67M 330
2015
Q3
$1.67M Buy
+257,592
New +$2.7M 0.19% 172

Other funds holding CC

Convergence Investment Partners's CC Position: Q1 2023 in Review

Convergence Investment Partners sold out of Chemours (CC) in Q1 2023, closing a stake of 32,385 shares — an estimated $992K sold.

Convergence Investment Partners first reported a position in CC in Q3 2015 and held it in 14 quarters. The position peaked at $3.64M in Q4 2016. 486 funds tracked by Wall St. Rank hold CC as of Q1 2023.

  • Convergence Investment Partners reported no remaining Chemours position as of Q1 2023 after selling out during the quarter.
  • Convergence Investment Partners sold 32,385 Chemours shares in Q1 2023, an estimated $992K.
  • Convergence Investment Partners first reported a position in Chemours in Q3 2015 and held it in 14 quarters.
  • Convergence Investment Partners's Chemours position peaked at $3.64M in Q4 2016.
  • 486 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on Convergence Investment Partners's 13F filing for Q1 2023, filed 9 May 2023.